Legend Biotech Corporation announced that it has appointed Dr. Corazon (Corsee) Dating Sanders, Dr. Darren Ji, and Mr. Philip Yau to the company’s Board of Directors. Dr. Sanders joined the Legend Biotech Board of Directors in May 2020. She has over 25 years of experience in the discovery and development of biopharmaceutical products addressing high unmet medical need disease areas. She was also a Member of the Genentech/Roche Late Stage Portfolio Committee from 2009 to 2017, and Global Head of the Genentech/Roche Late Stage Clinical Operations, covering the Americas, Europe, and Asia Pacific from 2012 to 2017. Dr. Sanders currently serves as a member of the Board of Directors of Molecular Templates Inc. and of AbGenomics International Inc.Dr. Ji joined the Legend Biotech Board of Directors in May 2020 and will serve as Chairperson of the Compensation Committee. In prior roles, he served as the Global Head and Vice President of F. Hofmann-La Roche Ltd. for Business Development in Asia and Emerging Markets. Dr. Ji was responsible for driving the strategy and execution of business development activities in a large territory encompassing over 100 countries. Currently, Dr. Ji is Chairman and CEO of Elpiscience Biopharmaceuticals Inc. He is also a Venture Partner of Lilly Asia Ventures (LAV). Mr. Yau joined the Legend Biotech Board of Directors in May 2020 and will serve as Chairperson of the Audit Committee. Most recently, Mr. Yau served as the non-Executive Vice Chairman and Group Chief Financial Officer at AMTD Group where he led the strategy development, corporate finance and investment function. Prior to that, he worked at Ernst & Young China Practice as a partner and risk advisor China South market leader, serving clients in Greater China. From January 2006 to July 2011, he worked at Protiviti Shanghai Co. Ltd.